A. Gila

1.2k total citations · 1 hit paper
27 papers, 894 citations indexed

About

A. Gila is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, A. Gila has authored 27 papers receiving a total of 894 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 12 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in A. Gila's work include Hepatitis C virus research (13 papers), Liver Disease Diagnosis and Treatment (10 papers) and Hepatitis B Virus Studies (6 papers). A. Gila is often cited by papers focused on Hepatitis C virus research (13 papers), Liver Disease Diagnosis and Treatment (10 papers) and Hepatitis B Virus Studies (6 papers). A. Gila collaborates with scholars based in Spain, United States and Switzerland. A. Gila's co-authors include A. Ruiz‐Extremera, Javier Salmerón, Manuel Romero‐Gómez, M. Diago, Paloma Muñoz‐de‐Rueda, María del Mar Viloria, Pilar López Serrano, Conrado Fernández‐Rodríguez, Raquel Corpas and Luis Alberto Vázquez and has published in prestigious journals such as Gastroenterology, PLoS ONE and Journal of Virology.

In The Last Decade

A. Gila

23 papers receiving 869 citations

Hit Papers

Insulin resistance impairs sustained response rate to peg... 2005 2026 2012 2019 2005 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Gila Spain 11 650 628 147 103 96 27 894
Colin Carr United Kingdom 3 262 0.4× 257 0.4× 107 0.7× 91 0.9× 107 1.1× 5 583
María Luisa Gutiérrez García Spain 12 845 1.3× 808 1.3× 120 0.8× 66 0.6× 64 0.7× 36 1.1k
Michael Estep United States 12 319 0.5× 159 0.3× 76 0.5× 152 1.5× 19 0.2× 21 491
Atsuhiro Morita Japan 10 265 0.4× 258 0.4× 44 0.3× 117 1.1× 16 0.2× 13 600
P. Giral France 8 287 0.4× 266 0.4× 64 0.4× 127 1.2× 39 0.4× 14 525
Masakatsu Uchihara Japan 13 423 0.7× 565 0.9× 26 0.2× 49 0.5× 16 0.2× 36 746
Rainer Günther Germany 12 434 0.7× 437 0.7× 38 0.3× 82 0.8× 16 0.2× 30 818
Maciej Jabłkowski Poland 9 294 0.5× 234 0.4× 60 0.4× 156 1.5× 17 0.2× 46 519
Tatsuya Itoshima Japan 12 283 0.4× 210 0.3× 45 0.3× 127 1.2× 59 0.6× 69 641
Longgen Liu China 14 251 0.4× 161 0.3× 25 0.2× 107 1.0× 15 0.2× 54 528

Countries citing papers authored by A. Gila

Since Specialization
Citations

This map shows the geographic impact of A. Gila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Gila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Gila more than expected).

Fields of papers citing papers by A. Gila

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Gila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Gila. The network helps show where A. Gila may publish in the future.

Co-authorship network of co-authors of A. Gila

This figure shows the co-authorship network connecting the top 25 collaborators of A. Gila. A scholar is included among the top collaborators of A. Gila based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Gila. A. Gila is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martin, D., et al.. (2024). Intensive Calcium Monitoring Following Parathyroidectomy: Prevention of Hungry Bone Syndrome in Children. Turkish Archives of Pediatrics. 59(1). 109–111.
2.
García, Emilio García, et al.. (2020). Manifestaciones endocrinas de los tumores germinales del sistema nervioso central en niños. Endocrinología Diabetes y Nutrición. 67(8). 540–544. 1 indexed citations
3.
Ruiz‐Extremera, A., Mário Florido, Paloma Muñoz de Rueda, et al.. (2017). Influence of HLA class I, HLA class II and KIRs on vertical transmission and chronicity of hepatitis C virus in children. PLoS ONE. 12(2). e0172527–e0172527. 8 indexed citations
4.
Rueda, Paloma Muñoz de, R. Quiles, Jorge Casado, et al.. (2017). The antigenic variability of HCV in viral HLA-Ag binding is related to the activation of the host immune response. Scientific Reports. 7(1). 15513–15513. 1 indexed citations
5.
Siguero, Juan Pedro López, et al.. (2017). Situación de la diabetes mellitus tipo 1 en Andalucía. Datos asistenciales, uso de terapias avanzadas y recursos humanos. Anales de Pediatría. 89(2). 111–116. 11 indexed citations
6.
Rica, Itxaso, et al.. (2014). Transición del paciente con diabetes tipo 1 desde la Unidad de Diabetes pediátrica a la Unidad de Diabetes de adultos. Avances en Diabetología. 30(3). 80–86. 5 indexed citations
7.
Ruiz‐Extremera, A., José Antonio Muñoz‐Gámez, Paloma Muñoz‐de‐Rueda, et al.. (2013). Variation of Transaminases, HCV-RNA Levels and Th1/Th2 Cytokine Production during the Post-Partum Period in Pregnant Women with Chronic Hepatitis C. PLoS ONE. 8(10). e75613–e75613. 13 indexed citations
8.
Muñoz‐de‐Rueda, Paloma, A. Gila, R. Quiles, et al.. (2012). Importance of IL-10 and IL-6 during chronic hepatitis c genotype-1 treatment and their relation with IL28B. Cytokine. 61(2). 595–601. 16 indexed citations
9.
Caballero, Teresa, et al.. (2012). Histological and immunohistochemical assessment of liver biopsies in morbidly obese patients.. PubMed. 27(4). 459–66. 13 indexed citations
10.
Cuartero, B. García, et al.. (2012). Ketoacidosis at onset of type 1 diabetes mellitus in pediatric age in Spain and review of the literature.. PubMed. 9(3). 669–71. 28 indexed citations
11.
Gila, A., et al.. (2011). Nuevos tratamientos de hepatitis C. Gastroenterología y Hepatología. 34(1). 58–65.
12.
Ruiz‐Extremera, A., R. Quiles, Ana Belén Barragán Martín, et al.. (2011). Plasma Ribavirin Trough Concentrations During Treatment of Chronic Hepatitis C in Genotype-1 Patients. Journal of Clinical Gastroenterology. 46(4). 328–333. 5 indexed citations
13.
Carazo, Ángel, Josefa León, Jorge Casado, et al.. (2011). Hepatic Expression of Adiponectin Receptors Increases with Non-alcoholic Fatty Liver Disease Progression in Morbid Obesity in Correlation with Glutathione Peroxidase 1. Obesity Surgery. 21(4). 492–500. 29 indexed citations
14.
Rueda, Paloma Muñoz de, Miguel Ángel López‐Nevot, Pablo Sáenz-López, et al.. (2011). Importance of Host Genetic Factors HLA and IL28B as Predictors of Response to Pegylated Interferon and Ribavirin. The American Journal of Gastroenterology. 106(7). 1246–1254. 30 indexed citations
15.
Salmerón, Javier, Jorge Casado, Paloma Muñoz de Rueda, et al.. (2008). Quasispecies as predictive factor of rapid, early and sustained virological responses in chronic hepatitis C, genotype 1, treated with peginterferon–ribavirin. Journal of Clinical Virology. 41(4). 264–269. 14 indexed citations
16.
Romero‐Gómez, Manuel, María del Mar Viloria, Raúl J. Andrade, et al.. (2005). Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology. 128(3). 636–641. 556 indexed citations breakdown →
17.
Salmerón, Javier & A. Gila. (2005). Hepatitis vírica aguda. Revista Española de Enfermedades Digestivas. 97(3). 213–213. 1 indexed citations
18.
Ruiz‐Extremera, A., et al.. (2005). Activity of hepatic enzymes from week sixteen of pregnancy. American Journal of Obstetrics and Gynecology. 193(6). 2010–2016. 10 indexed citations
19.
Gila, A., et al.. (2002). Desarrollo y diferenciación sexual normal. Dialnet (Universidad de la Rioja). 141–154. 1 indexed citations
20.
Gila, A., et al.. (1995). [Prospective study of the incidence of post-transfusion hepatitis after the exclusion of donors positive for anti-HCV ELISA 2].. PubMed. 105(17). 641–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026